Media-OutReach Newswire Zuellig Pharma and Karo Healthcare strengthen partnership across key markets in Asia
Media-OutReach Newswire Zuellig Pharma acquires Cialis® (Tadalafil) and Alimta® (Pemetrexed) from Lilly in select ASEAN markets
Media-OutReach Newswire Molex Expands European Manufacturing Footprint and Capabilities with State-of-the-Art Campus in Poland
Media-OutReach Newswire HSBC, Daiwa Capital Markets and Essence International Reiterate "Buy" Rating on Fosun International
Media-OutReach Newswire Zuellig Pharma awarded EcoVadis Platinum Medal for third consecutive year and rated leader in carbon management
Media-OutReach Newswire Domestic and Foreign Investment Banks, Including Citi, UBS, Nomura Orient, Industrial Securities, Huaxi Securities, and Kaiyuan Securities are Bullish on Fosun International’s Strong Profitability in Core Businesses and Sufficient Liquidity
Media-OutReach Newswire EVYD Technology, collaborates with the National University of Singapore Saw Swee Hock School of Public Health and Precision Public Health Asia Society for Leadership Forum to advance Precision Public Health in Asia
Media-OutReach Newswire GEODIS India celebrates 25 years of delivering Innovative, Sustainable and Ethical Logistics Solutions
Media-OutReach Newswire Fosun Participates in the 3rd BEYOND Expo to Deepen Biotechnology Innovation and Global Development
Media-OutReach Newswire Zuellig Pharma Recognised with A Score Of "A-" On CDP Supplier Engagement In Industry First
Media-OutReach Newswire CITIC Telecom CPC Continuous DX Innovation to Introduce Intelligence Operation Journey
Media-OutReach Newswire Caldic joins the global top league in ingredients and specialty chemicals distribution following merger with Connell
Media-OutReach Newswire IGIS Asia Investment Management Partners with CHA Bio Group to Launch Life Science Real Estate Platform JV
Gov't orders urgent preparations as northern Việt Nam faces rising threat of landslides, flash floods 4.
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.